Tumor cell sensitization method using quinazolinedione derivativ

Details Tumor cell sensitization method using quinazolinedione derivativ Tumor cell sensitization method using quinazolinedione derivativ

1990-03-21

1992-11-03

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

514 34, 514259, 514283, 514258, 514253, A61K 4900, A61K 3170, A61K 31525, A61K 3144

Patent

active

051607271

ABSTRACT:
A method for sensitizing cancer cells which have become resistant to treatment with one or more anticancer agents which comprises treating said cells with a quinazolinedione compound.

REFERENCES:
patent: 3819630 (1974-06-01), Parcell
patent: 4564616 (1986-01-01), Jones et al.
patent: 4578465 (1986-03-01), Nagano et al.
patent: 4705787 (1987-11-01), Ueda et al.
patent: 4981856 (1991-01-01), Hughes
A. Ramu, "Structure-Activity Relationship of Compounds that Restore Sensitivity to Doxorubicin in Drug-Resistant P388 Cells", Resistance to Antineoplastic Drugs, Ch. 5, pp. 63-80 (1987).

Affiliated with

Also associated with

Rating

Tumor cell sensitization method using quinazolinedione derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor cell sensitization method using quinazolinedione derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor cell sensitization method using quinazolinedione derivativ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2050784